Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung

衰老肺内皮再生的新信号传导和分子靶点

基本信息

  • 批准号:
    8909182
  • 负责人:
  • 金额:
    $ 39.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-15 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): An essential component of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is that injury of the endothelial barrier of pulmonary microvessels results in persistent increase in lung vascular permeability to protein and intractable protein-rich edema formation. Compared to young patients, the incidence of ALI/ARDS resulting from sepsis in elderly patients is as much as 19-fold greater and the mortality rate is up to 10-fold greater. However, the underlying causes are poorly understood. Also crucially little is known how aging influences mechanisms of endothelial regeneration and restoration of vascular homeostasis following sepsis challenge. We have recently shown that the Forkhead transcription factor FoxM1 is a key reparative factor responsible for endothelial regeneration. However, our new Supporting Data presented here show that FoxM1 expression and the endogenous endothelial regeneration program were severely impaired in aged lungs following inflammatory lung injury. We observed that endothelial hypoxia-inducible factor HIF-1a is the critical mediator of FoxM1 expression through transcriptional control of SDF-1a which activates CXCR4 receptor leading to activation of the GPCR-dependent p110gamma isoform of PI3K, and that inhibition of the oxygen sensors HIF prolyl hydroxylase (PHDs) re-induced FoxM1 expression and activated the endothelial regeneration program in aged lungs. Thus, we hypothesize that impaired HIF- 1a->FoxM1 signaling secondary to activation of PHD2 in aged lungs is responsible for the severely defective endothelial regeneration in these lungs, and activation of this fundamental reparative pathway through PHD2 inhibition and CXCR4 activation is a potential novel therapeutic approach for reversing lung microvessel leakiness and improving survival of elderly ALI/ARDS patients. The proposed studies address the following Specific Aims. In Aim #1, we will address the role of impaired HIF-1a->FoxM1 signaling in aged lungs as a crucial factor responsible for severely impaired endothelial regeneration and restoration of lung vascular homeostasis following sepsis challenge. In Aim #2, we will delineate the signaling mechanisms underlying severely defective endothelial regeneration in aged lungs following sepsis challenge. In Aim #3, we will determine the role of HIF-1a stabilization through PHD inhibition in activating endothelial regeneration in aged lungs. We will also address the potential clinical relevance of our findings in animal models to humans; thereby determine the therapeutic implications of inhibition of PHD2 and activation of CXCR4 in treatment of ALI/ARDS of elderly patients. With these comprehensive studies, we will delineate the fundamental signaling mechanisms of impaired endothelial regeneration in aged lungs, and identify therapeutic targets to activate this fundamental intrinsic HIF-1a->FoxM1-dependent mechanisms to repair leaky lung microvessels for the treatment of ALI/ARDS in elderly patients.
描述(申请人提供):急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)的一个重要组成部分是肺微血管内皮屏障的损伤导致肺血管对蛋白质的通透性持续增加和顽固性富含蛋白质的水肿形成。与年轻患者相比,老年患者脓毒症引起的ALI/ARDS的发生率高出19倍,死亡率高出10倍。然而,人们对根本原因知之甚少。同样至关重要的是,人们对衰老如何影响脓毒症后内皮再生和血管稳态恢复的机制知之甚少。我们最近发现 Forkhead 转录因子 FoxM1 是负责内皮再生的关键修复因子。然而,我们在此提供的新支持数据表明,在炎症性肺损伤后,衰老的肺部中 FoxM1 表达和内源性内皮再生程序严重受损。我们观察到,内皮缺氧诱导因子 HIF-1a 是 FoxM1 表达的关键介质,通过 SDF-1a 的转录控制激活 CXCR4 受体,从而激活 GPCR 依赖性的 PI3K p110gamma 亚型,并且抑制氧传感器 HIF 脯氨酰羟化酶 (PHD) 重新诱导 FoxM1 表达并激活 老化肺部的内皮再生程序。因此,我们假设老年肺中 PHD2 激活继发的 HIF-1a->FoxM1 信号受损是导致这些肺中严重缺陷的内皮再生的原因,并且通过 PHD2 抑制和 CXCR4 激活来激活这一基本修复途径是逆转肺微血管渗漏和改善老年人生存的潜在新治疗方法 ALI/ARDS 患者。拟议的研究涉及以下具体目标。在目标#1中,我们将探讨衰老肺部中受损的 HIF-1a->FoxM1 信号传导的作用,这是脓毒症挑战后严重受损的内皮再生和肺血管稳态恢复的关键因素。在目标#2中,我们将描述脓毒症挑战后老化肺部严重缺陷的内皮再生的信号传导机制。在目标 3 中,我们将确定通过 PHD 抑制来稳定 HIF-1a 在激活老化肺部内皮再生中的作用。我们还将探讨我们在动物模型中的研究结果与人类的潜在临床相关性;从而确定抑制 PHD2 和激活 CXCR4 在治疗老年患者 ALI/ARDS 中的治疗意义。通过这些全面的研究,我们将描述老年肺部内皮再生受损的基本信号传导机制,并确定治疗靶点来激活这种基本的内在 HIF-1a->FoxM1 依赖性机制,以修复渗漏的肺微血管,从而治疗老年患者的 ALI/ARDS。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOU-YANG ZHAO其他文献

YOU-YANG ZHAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOU-YANG ZHAO', 18)}}的其他基金

Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH
RNA修饰在肺血管重塑和PAH发病机制中的新作用
  • 批准号:
    10540134
  • 财政年份:
    2022
  • 资助金额:
    $ 39.28万
  • 项目类别:
Negative regulators of endothelial regeneration in aging lungs and ARDS
衰老肺和 ARDS 中内皮再生的负调节因子
  • 批准号:
    10467781
  • 财政年份:
    2022
  • 资助金额:
    $ 39.28万
  • 项目类别:
Negative regulators of endothelial regeneration in aging lungs and ARDS
衰老肺和 ARDS 中内皮再生的负调节因子
  • 批准号:
    10629328
  • 财政年份:
    2022
  • 资助金额:
    $ 39.28万
  • 项目类别:
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS
ARDS发病机制中内皮损伤的新机制
  • 批准号:
    10434658
  • 财政年份:
    2020
  • 资助金额:
    $ 39.28万
  • 项目类别:
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS
ARDS发病机制中内皮损伤的新机制
  • 批准号:
    10618326
  • 财政年份:
    2020
  • 资助金额:
    $ 39.28万
  • 项目类别:
Targeting Smooth Muscle Progenitor Cells for Treatment of Pulmonary Arterial Hypertension
靶向平滑肌祖细胞治疗肺动脉高压
  • 批准号:
    10189689
  • 财政年份:
    2018
  • 资助金额:
    $ 39.28万
  • 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
  • 批准号:
    10470871
  • 财政年份:
    2016
  • 资助金额:
    $ 39.28万
  • 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
  • 批准号:
    10316765
  • 财政年份:
    2016
  • 资助金额:
    $ 39.28万
  • 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
  • 批准号:
    10677597
  • 财政年份:
    2016
  • 资助金额:
    $ 39.28万
  • 项目类别:
Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung
衰老肺内皮再生的新信号传导和分子靶点
  • 批准号:
    9307973
  • 财政年份:
    2014
  • 资助金额:
    $ 39.28万
  • 项目类别:

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
  • 批准号:
    10720687
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
  • 批准号:
    10719249
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
  • 批准号:
    23K07651
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
  • 批准号:
    10679944
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
  • 批准号:
    10837431
  • 财政年份:
    2023
  • 资助金额:
    $ 39.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了